In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.
Nathan P. Jones, Oscar Contreras Velasco, John P. Sullivan, Chris Callaghan, Irina Chindea, Daniel Weisz ArgomedoOctober 18, 2023
Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.
The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.
As the world faces the latest wave of COVID-19, a vaccine produced by health fellow Peter Hotez and his colleague Maria Elena Bottazzi is ready to be deployed. Their CORBEVAX vaccine is inexpensive, effective, safe and easy to store and distribute, they write. Read their article in Scientific American: https://bit.ly/3n28isA
Peter J. Hotez, Maria Elena BottazziJanuary 6, 2022
"The framework of science tikkun — repairing the world through science and global scientific cooperation — offers a path for countering a new rise in antiscience aggression," writes fellow Peter Hotez in The FASEB Journal. Find his perspective on how here.
"This is a moment to prioritise health over short-term political calculations," write fellow Peter Hotez, Rekha Lakshmanan and nine other experts in a Lancet commentary. Click here for their call for action against anti-vaccine rhetoric and COVID-19 misinformation, and five short-term recommendations.
Rekha Lakshmanan, Peter J. HotezSeptember 17, 2021
The death of George Floyd has accelerated calls for police reform. Although decriminalizing drugs and the people who use them will not end police violence, it is part of the structural change needed to fix the problem, writes fellow Katharine Neill Harris.
The collective trauma of the Covid-19 pandemic may provide a clearer understanding of why people use drugs — to help us see it not as a moral failing or a brain malfunction, but as a fundamentally human response to negative life events. Read more at the Baker Institute Blog.
Fellow Katharine Neill Harris considers the validity of risk assessment tools, which estimate the likelihood that an individual who has been charged with or convicted of a crime will commit a future offense. Baker Institute Blog: https://bit.ly/2Cwl6jc